JEWISH TIME PODCAST JEWISH TIME PODCAST SUBSCRIBE TODAY SUBSCRIBE TODAY
search
coronavirus vaccine
This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (Pfizer via AP)
October 26, 2021, 10:47 am
FDA Expected to Authorize Pfizer COVID Vaccine for Kids 5-11
Israel planning to follow suit after its own approval process, as soon as mid-November.
By AFP and TOI STAFF
Israeli youth receive dose of the COVID-19 vaccine on September 20, 2021 in Jerusalem. Photo by Olivier Fitoussi/Flash90 ***
September 28, 2021, 7:52 pm
Pfizer Submits Initial COVID Vaccine Trial Data to FDA for Children Aged 5-11
Pharmaceutical company files information from study involving over 2,000 children; says not yet requesting emergency use authorization, but expected to do so in weeks.
By TOI STAFF
October 25, 2020, 3:42 pm
Human Trials for Israeli Coronavirus Vaccine to Begin November 1
Institute for Biological Research to carry out testing in three stages: first on 80 people, then 960 and finally on 30,000 volunteers before it will be cleared for full use.
By JUDAH ARI GROSS
Laboratory technicians work at the mAbxience biopharmaceutical company on an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca in Garin, Argentina, August 14, 2020. (Natacha Pisarenko/AP)
September 9, 2020, 6:28 am
AstraZeneca COVID-19 Vaccine Trial Paused After One Illness
Company investigating if a recipient’s ‘potentially unexplained’ illness is a side effect of shot, calls move ‘standard review process,’ in late-stage study.
By LAURAN NEERGAARD
Keren Pedersen (courtesy of Keren Pedersen)
July 3, 2020, 7:11 am
Infect Me: Keren, 29, Volunteers to Catch Coronavirus to Help End Pandemic
US-born ex-soldier, engineering student one of 61 in Israel to sign up for ‘challenge trial’ to advance vaccine research, despite risk of ‘death and very unpleasant complications’.
By NATHAN JEFFAY
A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle, on March 16, 2020. The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in a study volunteers who were given either a low or medium dose. (AP Photo/Ted S. Warren, File)
May 20, 2020, 6:55 am
Moderna’s Israeli Top Medical Officer: We’ve Shown that Our Vaccine Works
US biotech firm shares soar as it claims tests of first volunteers show its vaccine candidate produces immune response, ‘has potential to prevent COVID-19’; Phase 3 tests in July.
By TOI STAFF and AGENCIES
Mayanei Hayeshua Medical team treat a patient with coronavirus disease (COVID-19) at the coronavirus unit, in Mayanei Hayeshua Medical Center, Bnei Brak, Israel, April 13, 2020. Photo by Nati Shohat/Flash90
May 18, 2020, 7:09 am
Israeli Lab Completes Successful Coronavirus Vaccine Tests on Rodents – Report
Defense Ministry-run Institute for Biological Research said to prepare further experiments before moving on to human trials, hopes to have finished product within a year.
By TOI STAFF and AGENCIES
Load More